This motivated further exploration of the relative impact of Nrf2-induced neuroprotection in the context of nitroalkene modulation of other target responses in microglia, astrocytes, and non-dopaminergic neurons in other brain regions affected by PD. The gene discussed is NFE2L2; the disease is Parkinson disease.